As we suggested in earlier coverage, the Myer share price would struggle to break above resistance around the 75-cent mark. This has subsequently played out and the latest data out of National Australia Bank Ltd [ASX:NAB] points towards further declines.
The company has recently come out of a trading halt and provided clarification on its reserves. Meanwhile, there are signs that Lynas could benefit from worsening US–China trade war tensions.
The latest news out of the company is that it has received FDA clearance for its APAS® Independence instrument, which uses Artificial Intelligence (AI).
At time of writing, the share price of Lynas Corporation Ltd [ASX:LYC] is up 10.38%, trading at $2.18 per share. In the last three months, Lynas’ share price has seen a significant spike following a takeover bid from Wesfarmers Ltd [ASX:WES].
The latest news out of the company is that it has signed a Memorandum of Understanding (MoU) with a US company for a joint venture (JV) processing facility to be based in Texas.
There had been muted signs of a revival for the Yojee share price in the lead up to today’s announcement after a prolonged downturn. The latest news out of Yojee is that it has signed an important services agreement with a major logistics company.
The latest news out of DigitalX is that its Share Purchase Plan (SPP) has closed significantly oversubscribed. We will examine its prospects going forward
At time of writing, Bitcoin [BTC] has just broken through the US$8,000 dollar mark (a nine month high), but is currently trading $7,987.75. We look ahead to whether the cryptocurrency can sustain its run.
Despite a recent pullback, it has been an exciting ride for investors with the Orthocell share price going through the roof on 8 May .Today we will be looking at what caused Orthocell’s remarkable rise and its prospects going forward.
While Macquarie and ANZ are trading ex-dividend, the share price of CBA was down on the revelation that its third quarter profit fell 28% to $1.7 billion in the three months to March.